[HTML][HTML] Revisiting the cochlear and central mechanisms of tinnitus and therapeutic approaches

AJ Noreña - Audiology and Neurotology, 2015 - karger.com
This short review aims at revisiting some of the putative mechanisms of tinnitus. Cochlear-
type tinnitus is suggested to result from aberrant activity generated before or at the cochlear …

[HTML][HTML] Intrinsic mechanism and pharmacologic treatments of noise-induced hearing loss

K Xu, B Xu, J Gu, X Wang, D Yu, Y Chen - Theranostics, 2023 - ncbi.nlm.nih.gov
Noise accounts for one-third of hearing loss worldwide. Regretfully, noise-induced hearing
loss (NIHL) is deemed to be irreversible due to the elusive pathogenic mechanisms that …

Sensorineural tinnitus: its pathology and probable therapies

AR Møller - International journal of otolaryngology, 2016 - Wiley Online Library
Tinnitus is not a single disease but a group of different diseases with different pathologies
and therefore different treatments. Regarding tinnitus as a single disease is hampering …

[HTML][HTML] Cochlear NMDA receptors as a therapeutic target of noise-induced tinnitus

D Bing, SC Lee, D Campanelli, H Xiong… - Cellular Physiology and …, 2015 - karger.com
Background: Accumulating evidence suggests that tinnitus may occur despite normal
auditory sensitivity, probably linked to partial degeneration of the cochlear nerve and …

Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus—a double-blind, randomized, placebo-controlled phase II study

P Van de Heyning, G Muehlmeier, T Cox… - Otology & …, 2014 - journals.lww.com
Objective To evaluate the efficacy and safety of intratympanic AM-101 in patients with
persistent acute inner ear tinnitus after acute acoustic trauma, idiopathic sudden …

Ophthalmic and otic drug administration: novel approaches and challenges

A Desai, M Shukla, F Maulvi, K Ranch - Novel Drug Delivery Technologies …, 2019 - Springer
Disorders of the eye and ear severely influence the life of millions of people worldwide, but
management strategies for these disorders present the challenge primarily for the design of …

Safety of repeated-dose intratympanic injections with AM-101 in acute inner ear tinnitus

H Staecker, M Morelock, T Kramer… - … –Head and Neck …, 2017 - journals.sagepub.com
Objective To evaluate the safety and tolerability of repeated intratympanic administration of
the gel-formulated NMDA receptor antagonist AM-101 in acute patients with inner ear …

Otic drug delivery systems: formulation principles and recent developments

X Liu, M Li, H Smyth, F Zhang - Drug Development and Industrial …, 2018 - Taylor & Francis
Disorders of the ear severely impact the quality of life of millions of people, but the treatment
of these disorders is an ongoing, but often overlooked challenge particularly in terms of …

Selecting appropriate dose regimens for AM-101 in the intratympanic treatment of acute inner ear tinnitus

H Staecker, KS Maxwell, JR Morris… - Audiology and …, 2015 - karger.com
Inhibition of cochlear N-methyl-d-aspartate (NMDA) receptors with AM-101, a small
molecule antagonist delivered by intratympanic injection, represents a novel approach to …

Proficiency of virtual follow-up amongst tinnitus patients who underwent intratympanic steroid therapy amidst COVID 19 pandemic

S Vijayasundaram, P Karthikeyan, SD Mehta - American journal of …, 2020 - Elsevier
Aim The aim of this study was to assess the efficacy and feasibility of virtual follow-up in
patients who have undergone intratympanic steroid injection for treatment of tinnitus during …